Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Leukemia & Lymphoma|July 28, 2016
Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 PatientsH M Golomb, M J Ratain, A Fefer, et al.
American Journal of Medical Genetics|July 17, 1995
Analysis of variability of clinical manifestations in Waardenburg syndromeJ E Reynolds, J M Meyer, B Landa, et al.
Human Molecular Genetics|April 1, 1996
Phenotypic variation in Waardenburg syndrome: mutational heterogeneity, modifier genes or polygenic background?A Pandya, X J Xia, B L Landa, et al.
Hepatology (Baltimore, Md.)|March 8, 2000
Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trialR J Fontana, J Israel, P LeClair, et al.
Journal of the American Academy of Dermatology|October 8, 2017
Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trialsMark G Lebwohl, Kim A Papp, Lauren B Marangell, et al.
Micromachines|November 3, 2020
Characterization of Soft Tooling Photopolymers and Processes for Micromixing Devices with Variable Cross-SectionJ Israel Martínez-López, Héctor Andrés Betancourt Cervantes, Luis Donaldo Cuevas Iturbe, et al.
The Journal of Infectious Diseases|July 7, 2000
Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adultsJ M Jacobson, I Lowy, C V Fletcher, et al.
Micromachines|January 21, 2023
Low-Cost Light-Based GelMA 3D Bioprinting via Retrofitting: Manufacturability Test and Cell Culture AssessmentJuan Enrique Pérez-Cortez, Víctor Hugo Sánchez-Rodríguez, Salvador Gallegos-Martínez, et al.
American Journal of Human Genetics|October 31, 2000
Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotypeG A Bellus, E B Spector, P W Speiser, et al.
The Journal of Infectious Diseases|November 9, 2000
Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study TeamW T Shearer, R J Israel, S Starr, et al.
Pageof 14